CytoResc – “CytoSorb” Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: Approximately 8 - 10 % of COVID-19 patients present with a serious clinical course and need for hospitalization, 8% of hospitalized patients need ICU-treatment. Currently, no causal therapy is available and treatment is purely supportive. The main reason for death in critically ill patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Stockmann, Helena, Keller, Theresa, Büttner, Stefan, Jörres, Achim, Kindgen-Milles, Detlef, Kunz, Julius Valentin, Leebmann, Josef, Spies, Claudia, Träger, Karl, Treskatsch, Sascha, Uhrig, Alexander, Willam, Carsten, Enghard, Philipp, Slowinski, Torsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316574/
https://www.ncbi.nlm.nih.gov/pubmed/32586396
http://dx.doi.org/10.1186/s13063-020-04501-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316574/
https://www.ncbi.nlm.nih.gov/pubmed/32586396
http://dx.doi.org/10.1186/s13063-020-04501-0

Ejemplares similares